Tech Company Financing Transactions
Nucleus RadioPharma Funding Round
Nucleus RadioPharma closed a Series A financing round on 6/5/2024. Investors included AstraZeneca, Echo Global and Eclipse Ventures.
Transaction Overview
Company Name
Announced On
6/5/2024
Transaction Type
Venture Equity
Amount
Unknown
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to expand its development, supply, and commercial manufacturing capabilities to make targeted radiotherapies and theranostics more accessible to patients globally.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Rochester, MN Undisclosed
USA
Rochester, MN Undisclosed
USA
Phone
Undisclosed
Website
Email Address
Overview
Founded by Eclipse Ventures and Mayo Clinic, Nucleus RadioPharma is a new company built to ensure cancer patients can access potentially life-saving radiopharmaceuticals by developing technologies to modernize the clinical development, manufacturing, and supply chain of these promising new treatment tools.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Charles Conroy
Browse more venture capital transactions:
Prev: 6/5/2024: Plancraft venture capital transaction
Next: 6/5/2024: Sofie BioSciences venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on funding rounds that are announced publicly. VC transactions reported here are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs